Inhibition of FGFR4 increases oxaliplatin and 5-fluorouracil sensitivity in Kras wild-type and mutant colorectal cancer cells. This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting I.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results